Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.7430
-0.0559 (-7.00%)
At close: Jun 26, 2026, 4:00 PM EDT
0.7500
+0.0070 (0.94%)
After-hours: Jun 26, 2026, 7:33 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
117.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| ADC Therapeutics | 79.18M |
| Spero Therapeutics | 61.19M |
| Coya Therapeutics | 7.94M |
| NRx Pharmaceuticals | 2.29M |
| Humacyte | 2.02M |
| Connect Biopharma Holdings | 233.00K |
| Genelux | 8.00K |
GUTS News
- 16 days ago - Fractyl Health Transcript: AGM 2026 - Transcripts
- 22 days ago - Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - GlobeNewsWire
- 25 days ago - Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy - GlobeNewsWire
- 6 weeks ago - Fractyl Health Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Fractyl Health reports Q1 EPS 6c, consensus (16c) - TheFly
- 6 weeks ago - Fractyl Health Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Fractyl Health Earnings release: Q1 2026 - Filings
- 6 weeks ago - Fractyl Health Quarterly report: Q1 2026 - Filings